Dyne Therapeutics Stock Probability of Future Stock Price Finishing Over 38.55
| DYN Stock | USD 23.72 0.75 3.06% |
Dyne |
Dyne Therapeutics Target Price Odds to finish over 38.55
The tendency of Dyne Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 38.55 or more in 90 days |
| 23.72 | 90 days | 38.55 | near 1 |
Based on a normal probability distribution, the odds of Dyne Therapeutics to move over $ 38.55 or more in 90 days from now is near 1 (This Dyne Therapeutics probability density function shows the probability of Dyne Stock to fall within a particular range of prices over 90 days) . Probability of Dyne Therapeutics price to stay between its current price of $ 23.72 and $ 38.55 at the end of the 90-day period is roughly 97.0 .
Considering the 90-day investment horizon Dyne Therapeutics has a beta of 0.19 suggesting as returns on the market go up, Dyne Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Dyne Therapeutics will be expected to be much smaller as well. Additionally Dyne Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Dyne Therapeutics Price Density |
| Price |
Predictive Modules for Dyne Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Dyne Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Dyne Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Dyne Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Dyne Therapeutics is not an exception. The market had few large corrections towards the Dyne Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Dyne Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Dyne Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.52 | |
β | Beta against Dow Jones | 0.19 | |
σ | Overall volatility | 3.29 | |
Ir | Information ratio | -0.14 |
Dyne Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Dyne Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Dyne Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Dyne Therapeutics generated a negative expected return over the last 90 days | |
| Dyne Therapeutics has high historical volatility and very poor performance | |
| Reported Net Loss for the year was (235.94 M) with profit before taxes, overhead, and interest of 0. | |
| Dyne Therapeutics has about 291.84 M in cash with (188.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.64. | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from benzinga.com: Vistras Options A Look at What the Big Money is Thinking |
Dyne Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Dyne Stock often depends not only on the future outlook of the current and potential Dyne Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Dyne Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 59.7 M | |
| Cash And Short Term Investments | 123.1 M |
Dyne Therapeutics Technical Analysis
Dyne Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Dyne Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Dyne Therapeutics. In general, you should focus on analyzing Dyne Stock price patterns and their correlations with different microeconomic environments and drivers.
Dyne Therapeutics Predictive Forecast Models
Dyne Therapeutics' time-series forecasting models is one of many Dyne Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Dyne Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Dyne Therapeutics
Checking the ongoing alerts about Dyne Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Dyne Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Dyne Therapeutics generated a negative expected return over the last 90 days | |
| Dyne Therapeutics has high historical volatility and very poor performance | |
| Reported Net Loss for the year was (235.94 M) with profit before taxes, overhead, and interest of 0. | |
| Dyne Therapeutics has about 291.84 M in cash with (188.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.64. | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from benzinga.com: Vistras Options A Look at What the Big Money is Thinking |
Check out Dyne Therapeutics Backtesting, Dyne Therapeutics Valuation, Dyne Therapeutics Correlation, Dyne Therapeutics Hype Analysis, Dyne Therapeutics Volatility, Dyne Therapeutics History as well as Dyne Therapeutics Performance. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyne Therapeutics. If investors know Dyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyne Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.58) | Return On Assets (0.40) | Return On Equity (0.69) |
The market value of Dyne Therapeutics is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dyne Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyne Therapeutics' market value can be influenced by many factors that don't directly affect Dyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dyne Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyne Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyne Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.